{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:44:52Z","timestamp":1779342292809,"version":"3.51.4"},"reference-count":99,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Coronavirus Variants Rapid Response Network","award":["156941"],"award-info":[{"award-number":["156941"]}]},{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","award":["N\/A, in-kind support through Pandemic Response Cha"],"award-info":[{"award-number":["N\/A, in-kind support through Pandemic Response Cha"]}],"id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["424425"],"award-info":[{"award-number":["424425"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COVID-19 Immunity Task Force","award":["N\/A, additional funds for CIHR grant 424425"],"award-info":[{"award-number":["N\/A, additional funds for CIHR grant 424425"]}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","award":["N\/A, no grant or award number"],"award-info":[{"award-number":["N\/A, no grant or award number"]}],"id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To investigate the robustness and longevity of SARS-CoV-2 immune responses conferred by natural infection and vaccination among priority populations such as immunocompromised individuals and people with post-acute sequelae of COVID-19 in a prospective cohort study (Stop the Spread Ottawa\u2014SSO) in adults living in the Ottawa region. In this paper, we describe the study design, ongoing data collection and baseline characteristics of participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Since October 2020, participants who tested positive for COVID-19 (convalescents) or at high risk of exposure to the virus (under surveillance) have provided monthly blood and saliva samples over a 10-month period. As of 2 November 2021, 1026 adults had completed the baseline survey and 976 had attended baseline bloodwork. 300 participants will continue to provide bimonthly blood samples for 24 additional months (ie, total follow-up of 34 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings to date<\/jats:title><jats:p>The median age of the baseline sample was 44 (IQR 23, range: 18\u201379) and just over two-thirds (n=688; 67.1%) were female. 255 participants (24.9%) had a history of COVID-19 infection confirmed by PCR and\/or serology. Over 600 participants (60.0%) work in high-risk occupations (eg, healthcare, teaching and transportation). 108 participants (10.5%) reported immunocompromising conditions or treatments at baseline (eg, cancer, HIV, other immune deficiency, and\/or use of immunosuppressants).<\/jats:p><\/jats:sec><jats:sec><jats:title>Future plans<\/jats:title><jats:p>SSO continues to yield rich research potential, given the collection of pre-vaccine baseline data and samples from the majority of participants, recruitment of diverse subgroups of interest, and a high level of participant retention and compliance with monthly sampling. The 24-month study extension will maximise opportunities to track SARS-CoV-2 immunity and vaccine efficacy, detect and characterise emerging variants, and compare subgroup humoral and cellular response robustness and persistence.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-062187","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:37:42Z","timestamp":1662651462000},"page":"e062187","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Cohort profile:<b>S<\/b>top the Spread Ottawa (SSO)<i>\u2014<\/i>a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4209-1786","authenticated-orcid":false,"given":"Erin","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Bosveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliisa","family":"Heiskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Keeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Nakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khatereh","family":"Shir-Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3355-4950","authenticated-orcid":false,"given":"Frederic","family":"St-Denis-Bissonnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tamblyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agatha","family":"Vranjkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah C","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Arianne","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7453-7922","authenticated-orcid":false,"given":"Angela M","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-5531","authenticated-orcid":false,"given":"Julian","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaeline","family":"McGuinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Saginur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-3029","authenticated-orcid":false,"given":"Marc-Andr\u00e9","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis L","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"2022120600450507000_12.9.e062187.1"},{"key":"2022120600450507000_12.9.e062187.2","unstructured":"WHO . Coronavirus (COVID-19) Dashboard, 2022. Available: https:\/\/covid19.who.int\/ [Accessed January 3, 2022]."},{"key":"2022120600450507000_12.9.e062187.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102246","article-title":"The emergence of new SARS-CoV-2 variant (omicron) and increasing calls for COVID-19 vaccine boosters-the debate continues","volume":"45","author":"Khan","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"2022120600450507000_12.9.e062187.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00631-x"},{"key":"2022120600450507000_12.9.e062187.5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101342","article-title":"Immune responses against SARS-CoV-2-Questions and experiences","volume":"9","author":"Mangge","year":"2021","journal-title":"Biomedicines"},{"key":"2022120600450507000_12.9.e062187.6","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2666-5247(21)00219-6","article-title":"The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study","volume":"2","author":"Townsend","year":"2021","journal-title":"Lancet Microbe"},{"key":"2022120600450507000_12.9.e062187.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245532"},{"key":"2022120600450507000_12.9.e062187.8","article-title":"Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?","volume":"11","author":"Bajaj","year":"2020","journal-title":"Front Physiol"},{"key":"2022120600450507000_12.9.e062187.9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s43587-021-00156-x","article-title":"Research and resource needs for understanding host immune responses to SARS-CoV-2 and COVID-19 vaccines during aging","volume":"1","author":"PrabhuDas","year":"2021","journal-title":"Nat Aging"},{"key":"2022120600450507000_12.9.e062187.10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2021.09.055","article-title":"Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"162","author":"Sakuraba","year":"2022","journal-title":"Gastroenterology"},{"key":"2022120600450507000_12.9.e062187.11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10875-021-01046-y","article-title":"Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency","volume":"41","author":"Kinoshita","year":"2021","journal-title":"J Clin Immunol"},{"key":"2022120600450507000_12.9.e062187.12","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2665-9913(21)00212-5","article-title":"The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study","volume":"3","author":"Mahil","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2022120600450507000_12.9.e062187.13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2022120600450507000_12.9.e062187.14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021020188"},{"key":"2022120600450507000_12.9.e062187.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.912571","article-title":"Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study","volume":"13","author":"Shields","year":"2022","journal-title":"Front Immunol"},{"key":"2022120600450507000_12.9.e062187.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30701-5"},{"key":"2022120600450507000_12.9.e062187.17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2020.19719","article-title":"Long-Term health consequences of COVID-19","volume":"324","author":"del Rio","year":"2020","journal-title":"JAMA"},{"key":"2022120600450507000_12.9.e062187.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00522-1"},{"key":"2022120600450507000_12.9.e062187.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n853"},{"key":"2022120600450507000_12.9.e062187.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102927"},{"key":"2022120600450507000_12.9.e062187.21","doi-asserted-by":"crossref","unstructured":"Mehrabi Nejad MM , Shobeiri P , Dehghanbanadaki H , et al . Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; a systematic review and meta-analysis. Virol J 2022;19:132 doi:10.1186\/s12985-022-01858-3, PMID: 35941646 doi:10.1186\/s12985-022-01858-3","DOI":"10.1186\/s12985-022-01858-3"},{"key":"2022120600450507000_12.9.e062187.22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184621","article-title":"Responses to SARS-CoV-2 vaccination in patients with cancer (recover study): a prospective cohort study of the Hellenic Cooperative Oncology Group","volume":"13","author":"Linardou","year":"2021","journal-title":"Cancers"},{"key":"2022120600450507000_12.9.e062187.23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/tri.14029","article-title":"SARS-CoV-2 vaccination in solid-organ transplant recipients: what the clinician needs to know","volume":"34","author":"Giannella","year":"2021","journal-title":"Transpl Int"},{"key":"2022120600450507000_12.9.e062187.24","doi-asserted-by":"crossref","unstructured":"Rincon-Arevalo H , Choi M , Stefanski A-L , et al . Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol 2021;6 doi:10.1126\/sciimmunol.abj1031, PMID: 34131023 doi:10.1126\/sciimmunol.abj1031","DOI":"10.1126\/sciimmunol.abj1031"},{"key":"2022120600450507000_12.9.e062187.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01219-7","article-title":"Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia","volume":"15","author":"Parry","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2022120600450507000_12.9.e062187.26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/cei\/uxab018","article-title":"SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Rresearch Consortium study","volume":"207","author":"Shields","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2022120600450507000_12.9.e062187.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3026"},{"key":"2022120600450507000_12.9.e062187.28","doi-asserted-by":"crossref","unstructured":"Skyrud K , Hern\u00e6s KH , Telle K , et al . Impacts of COVID-19 on long-term health and health care use. medRxiv 2021.doi:10.1101\/2021.02.16.21251807","DOI":"10.1101\/2021.02.16.21251807"},{"key":"2022120600450507000_12.9.e062187.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z"},{"key":"2022120600450507000_12.9.e062187.30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.cmi.2021.07.024","article-title":"Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study","volume":"27","author":"Buonfrate","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022120600450507000_12.9.e062187.31","unstructured":"Government of Canada . Emerging COVID-19 research gaps and priorities. Available: https:\/\/www.canada.ca\/en\/institutes-health-research\/news\/2022\/03\/emerging-covid-19-research-gaps-and-priorities.html [Accessed 4 March 2022]."},{"key":"2022120600450507000_12.9.e062187.32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41564-021-00974-0","article-title":"Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern","volume":"6","author":"Dupont","year":"2021","journal-title":"Nat Microbiol"},{"key":"2022120600450507000_12.9.e062187.33","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(21)00253-1"},{"key":"2022120600450507000_12.9.e062187.34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat Rev Genet"},{"key":"2022120600450507000_12.9.e062187.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02758-6\/ATTACHMENT\/FB9D1AF8-6927-48BD-B7B7-A5055C3743D5\/MMC1.PDF"},{"key":"2022120600450507000_12.9.e062187.36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jmv.27281","article-title":"Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: a systematic review and meta-analysis","volume":"94","author":"Sotoodeh Ghorbani","year":"2022","journal-title":"J Med Virol"},{"key":"2022120600450507000_12.9.e062187.37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101299","article-title":"Sars CoV2 infection _The longevity study perspectives","volume":"67","author":"Lio","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2022120600450507000_12.9.e062187.38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiab127","article-title":"Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2","volume":"224","author":"Grzelak","year":"2021","journal-title":"J Infect Dis"},{"key":"2022120600450507000_12.9.e062187.39","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179357","article-title":"Improving social justice in COVID-19 health research: interim guidelines for reporting health equity in observational studies","volume":"18","author":"Antequera","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2022120600450507000_12.9.e062187.40","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23649"},{"key":"2022120600450507000_12.9.e062187.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0474-z"},{"key":"2022120600450507000_12.9.e062187.42","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab005","article-title":"SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: viral load predicts antibody response","volume":"8","author":"Masi\u00e1","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022120600450507000_12.9.e062187.43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022120600450507000_12.9.e062187.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00284-021-02724-1","article-title":"Emerging SARS-CoV-2 variants: genetic variability and clinical implications","volume":"79","author":"Dubey","year":"2022","journal-title":"Curr Microbiol"},{"key":"2022120600450507000_12.9.e062187.45","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHOM.2020.11.007"},{"key":"2022120600450507000_12.9.e062187.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031364"},{"key":"2022120600450507000_12.9.e062187.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00662-410.1038\/s41577-021-00662-4"},{"key":"2022120600450507000_12.9.e062187.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.04.015"},{"key":"2022120600450507000_12.9.e062187.49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"2022120600450507000_12.9.e062187.50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110629","article-title":"SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia","volume":"130","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2022120600450507000_12.9.e062187.51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141206"},{"key":"2022120600450507000_12.9.e062187.52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jmv.27287","article-title":"Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity","volume":"94","author":"Dolscheid-Pommerich","year":"2022","journal-title":"J Med Virol"},{"key":"2022120600450507000_12.9.e062187.53","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cmi.2021.05.033","article-title":"Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients","volume":"27","author":"Peghin","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022120600450507000_12.9.e062187.54","doi-asserted-by":"crossref","unstructured":"See\u00dfle J , Waterboer T , Hippchen T , et al . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis 2021.doi:10.1093\/cid\/ciab611","DOI":"10.1093\/cid\/ciab611"},{"key":"2022120600450507000_12.9.e062187.55","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9101075","article-title":"Humoral and cellular vaccination responses against SARS-CoV-2 in hematopoietic stem cell transplant recipients","volume":"9","author":"Lindemann","year":"2021","journal-title":"Vaccines"},{"key":"2022120600450507000_12.9.e062187.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2098"},{"key":"2022120600450507000_12.9.e062187.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100283"},{"key":"2022120600450507000_12.9.e062187.58","doi-asserted-by":"publisher","DOI":"10.1086\/500469"},{"key":"2022120600450507000_12.9.e062187.59","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","article-title":"Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection","volume":"184","author":"Anderson","year":"2021","journal-title":"Cell"},{"key":"2022120600450507000_12.9.e062187.60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2021.08.026","article-title":"Cross-Reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities","volume":"111","author":"Imai","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2022120600450507000_12.9.e062187.61","doi-asserted-by":"crossref","unstructured":"Lv H , Wu NC , Tsang OT-Y , et al . Cross-Reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep 2020;31:107725.doi:10.1016\/j.celrep.2020.107725","DOI":"10.1016\/j.celrep.2020.107725"},{"key":"2022120600450507000_12.9.e062187.62","doi-asserted-by":"crossref","first-page":"100189","DOI":"10.1016\/j.xcrm.2020.100189","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Rep Med"},{"key":"2022120600450507000_12.9.e062187.63","doi-asserted-by":"crossref","unstructured":"Okba NMA , M\u00fcller MA , Li W , et al . Severe acute respiratory syndrome coronavirus 2\u2212specific antibody responses in coronavirus disease patients. Emerging Infectious Diseases journal - CDC 2020;26.doi:10.3201\/eid2607.200841","DOI":"10.3201\/eid2607.200841"},{"key":"2022120600450507000_12.9.e062187.64","doi-asserted-by":"crossref","first-page":"103700","DOI":"10.1016\/j.ebiom.2021.103700","article-title":"Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2","volume":"74","author":"Galipeau","year":"2021","journal-title":"EBioMedicine"},{"key":"2022120600450507000_12.9.e062187.65","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022120600450507000_12.9.e062187.66","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00436-4"},{"key":"2022120600450507000_12.9.e062187.67","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-CoV-2-specific T cells in infection and vaccination","volume":"18","author":"Bertoletti","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2022120600450507000_12.9.e062187.68","doi-asserted-by":"crossref","unstructured":"Geers D , Shamier MC , Bogers S , et al . SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol 2021;6 doi:10.1126\/sciimmunol.abj1750, PMID: 34035118 doi:10.1126\/sciimmunol.abj1750","DOI":"10.1126\/sciimmunol.abj1750"},{"key":"2022120600450507000_12.9.e062187.69","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1093\/cid\/ciab938","article-title":"A higher antibody response is generated with a 6- to 7-week (vs standard) severe acute respiratory syndrome coronavirusHigher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccine dosing interval","volume":"75","author":"Grunau","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022120600450507000_12.9.e062187.70","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S2213-2600(21)00366-0","article-title":"Heterologous ChAdOx1-nCoV19-BNT162b2 vaccination provides superior immunogenicity against COVID-19","volume":"9","author":"Richardson","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022120600450507000_12.9.e062187.71","doi-asserted-by":"crossref","first-page":"2100634","DOI":"10.2807\/1560-7917.ES.2021.26.28.2100634","article-title":"Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March\u2212June 2021, England","volume":"26","author":"Powell","year":"2021","journal-title":"Eurosurveillance"},{"key":"2022120600450507000_12.9.e062187.72","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2022120600450507000_12.9.e062187.73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/vaccines10010046","article-title":"Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: results from the nationwide VAXILONG study","volume":"10","author":"Scherlinger","year":"2022","journal-title":"Vaccines"},{"key":"2022120600450507000_12.9.e062187.74","doi-asserted-by":"crossref","DOI":"10.3390\/v13061025","article-title":"Insights into SARS-CoV-2 persistence and its relevance","volume":"13","author":"Desimmie","year":"2021","journal-title":"Viruses"},{"key":"2022120600450507000_12.9.e062187.75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253007","article-title":"Screening for SARS-CoV-2 by RT-PCR: saliva or nasopharyngeal swab? Rapid review and meta-analysis","volume":"16","author":"Ibrahimi","year":"2021","journal-title":"PLoS One"},{"key":"2022120600450507000_12.9.e062187.76","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11020363","article-title":"Diagnosis of SARS-Cov-2 infection by RT-PCR using specimens other than naso- and oropharyngeal swabs: a systematic review and meta-analysis","volume":"11","author":"Moreira","year":"2021","journal-title":"Diagnostics"},{"key":"2022120600450507000_12.9.e062187.77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/diseases9020038","article-title":"Saliva exhibits high sensitivity and specificity for the detection of SARS-COV-2","volume":"9","author":"Warsi","year":"2021","journal-title":"Diseases"},{"key":"2022120600450507000_12.9.e062187.78","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3201\/eid2612.203309","article-title":"Sensitive detection of SARS-CoV-2-specific antibodies in dried blood spot samples","volume":"26","author":"Morley","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2022120600450507000_12.9.e062187.79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261003","article-title":"Dried blood spot specimens for SARS-CoV-2 antibody testing: a multi-site, multi-assay comparison","volume":"16","author":"Cholette","year":"2021","journal-title":"PLoS One"},{"key":"2022120600450507000_12.9.e062187.80","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1380","article-title":"A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination","volume":"11","author":"Colwill","year":"2022","journal-title":"Clin Transl Immunology"},{"key":"2022120600450507000_12.9.e062187.81","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)00527-4","article-title":"WHO international standard for anti-SARS-CoV-2 immunoglobulin","volume":"397","author":"Kristiansen","year":"2021","journal-title":"Lancet"},{"key":"2022120600450507000_12.9.e062187.82","unstructured":"DNA Genotek - Saliva Microbiome DNA and RNA Collection Kit. Available: https:\/\/www.dnagenotek.com\/ROW\/products\/collection-infectious-disease\/omnigene-oral\/OM-505.html [Accessed 26 Jun 2022]."},{"key":"2022120600450507000_12.9.e062187.83","unstructured":"Saliva collection handbook. Salimetrics., Published June 27, 2017. Available: https:\/\/salimetrics.com\/saliva-collection-handbook\/ [Accessed 26 Jun 2022]."},{"key":"2022120600450507000_12.9.e062187.84","unstructured":"Salivary detection of COVID-19 | Annals of internal medicine. Available: https:\/\/www.acpjournals.org\/doi\/full\/10.7326\/M20-4738 [Accessed 26 Jun 2022]."},{"key":"2022120600450507000_12.9.e062187.85","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"key":"2022120600450507000_12.9.e062187.86","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003573"},{"key":"2022120600450507000_12.9.e062187.87","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20220026"},{"key":"2022120600450507000_12.9.e062187.88","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jogc.2022.02.017","article-title":"Universal SARS-CoV-2 testing among obstetrical patients (UNIVERSE-OB) in Ottawa, Canada","volume":"44","author":"Alibhai","year":"2022","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"2022120600450507000_12.9.e062187.89","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2666-7568(22)00012-5","article-title":"Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (uncover): an interim report from a prospective observational cohort study","volume":"3","author":"Vinh","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"2022120600450507000_12.9.e062187.90","doi-asserted-by":"crossref","unstructured":"Anand SS , Arnold C , Bangdiwala S , et al . What factors converged to create a COVID-19 hot-spot? lessons from the South Asian community in Ontario. medRxiv 2022 https:\/\/doi.org\/10.1101\/2022.04.01.22273252 doi:10.1101\/2022.04.01.22273252","DOI":"10.1101\/2022.04.01.22273252"},{"key":"2022120600450507000_12.9.e062187.91","unstructured":"Government of Canada SC . COVID-19 infection in the Canadian household population, 2022. Available: https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-003-x\/2022004\/article\/00003-eng.htm [Accessed 6 Jul 2022]."},{"key":"2022120600450507000_12.9.e062187.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2017.06.009"},{"key":"2022120600450507000_12.9.e062187.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2019.03.009"},{"key":"2022120600450507000_12.9.e062187.94","doi-asserted-by":"crossref","unstructured":"Abe KT , Li Z , Samson R , et al . A simple protein-based surrogate neutralization assay for SARS-CoV-2. JCI Insight 2020;5.doi:10.1172\/jci.insight.142362","DOI":"10.1172\/jci.insight.142362"},{"key":"2022120600450507000_12.9.e062187.95","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441"},{"key":"2022120600450507000_12.9.e062187.96","doi-asserted-by":"crossref","unstructured":"Domingo FR , Waddell LA , Cheung AM , et al . Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. medRxiv 2021 https:\/\/doi.org\/10.1101\/2021.06.03.21258317 doi:10.1101\/2021.06.03.21258317","DOI":"10.1101\/2021.06.03.21258317"},{"key":"2022120600450507000_12.9.e062187.97","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac136"},{"key":"2022120600450507000_12.9.e062187.98","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jamiaopen\/ooaa062","article-title":"A primer on Bayesian estimation of prevalence of COVID-19 patient outcomes","volume":"3","author":"Gao","year":"2021","journal-title":"JAMIA Open"},{"key":"2022120600450507000_12.9.e062187.99","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054208","article-title":"CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study","volume":"11","author":"Costiniuk","year":"2021","journal-title":"BMJ Open"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-062187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T13:34:44Z","timestamp":1676727284000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-062187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":99,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjopen-2022-062187"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-062187","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}